AJCC	American Joint Committee on Cancer
BOT	Borderline ovarian tumor
CA	Cystadenoma
DAB	3,3′-diaminobenzidine
ECOG	Eastern Cooperative Oncology Group
FFPE	Formalin-fixed paraffin-embedded
FIGO	International Federation of Gynecology and Obstetrics
H&E	Hematoxylin and eosin
HGSC	High-grade serous ovarian carcinoma
HRD	Homologous recombination deficiency
ICD-10	International Classification of Diseases, 10th Revision
IHC	Immunohistochemistry
LGSC	Low-grade serous ovarian carcinoma
LOH	Loss of heterozygosity
LST	Large-scale state transitions
MHC	Major histocompatibility complex
NGS	Next-generation sequencing
OC	Ovarian cancer
ROI	Region of interest
PCR	Polymerase chain reaction
TAI	Telomeric allelic imbalance
TCR	T-cell receptor
TILs	Tumor-infiltrating lymphocytes
TIME	Tumor immune microenvironment
TLA	Three-letter acronym
TMB	Tumor mutational burden
TME	Tumor microenvironment
Tregs	Regulatory T-cells
WHO	World Health Organization